ENRT News Alert Enertopia Corporatio (ENRT) 0.0579 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 28, 2014 at 11:00 AM

Enertopia Corporatio (ENRT) 0.0579 $ENRT

Enertopia Submits MMPR Application For Burlington JV & Builds Awareness
ACCESSWIRE - Wed Sep 24, 9:46AM CDT
Whitefish, MT / September 24, 2014 / Enertopia Corp., (OTC: ENRT) an aspiring Licensed Producer of medical marijuana under Canada's Marihuana for Medical Purposes Regulations ("MMPR"

program, recently announced progress across two of its projects and new efforts to raise awareness among both physicians and consumers within an industry that Health Canada expects to reach C$1.3 billion by 2024.

Lexaria Makes Progress on Numerous Fronts
ACCESSWIRE - Tue Sep 23, 9:00AM CDT
Whitefish, MT / September 23, 2014 / Lexaria Corporation, an aspiring Licensed Producer of medical marijuana under Canada's Marihuana for Medical Purposes ("MMPR"

program, has made significant progress across several of its projects. The company has also launched a new program to raise awareness of medical marijuana's benefits among physicians and consumers throughout Canada.

World of Marihuana Joint Venture Update
ACCESSWIRE - Thu Sep 18, 4:08PM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Lexaria Launches National Medical Marijuana Outreach Plan
ACCESSWIRE - Thu Sep 18, 7:14AM CDT
National Medical Marijuana Outreach Plan

National Medical Marihuana Awareness and Outreach Strategy
ACCESSWIRE - Thu Sep 18, 7:04AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Lexaria Corp.: National Medical Marihuana Outreach Plan
Newsfile Corp - Thu Sep 18, 7:02AM CDT
full story)

Enertopia Provides Burlington Lexaria JV Update
ACCESSWIRE - Wed Sep 17, 7:04AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Lexaria Corp.: Health Canada Marijuana License Application Submitted
Newsfile Corp - Wed Sep 17, 7:01AM CDT
full story)

Lexaria Submits Health Canada Marijuana License Application
ACCESSWIRE - Tue Sep 16, 7:05AM CDT
Health Canada Marijuana License Application Submitted

Enertopia Provides Update on The Green Canvas JV
ACCESSWIRE - Tue Sep 16, 7:04AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Enertopia Makes Steady Progress as Industry Heats Up
ACCESSWIRE - Mon Aug 25, 9:10AM CDT
WHITEFISH, MT / ACCESSWIRE / August 25, 2014 / Canada's Marihuana for Medical Purposes Regulations ("MMPR"

program has been mired in controversy since the beginning. After switching from the Medical Marihuana Access Regulations ("MMAR"

to the MMPR program in October 1, 2013, Personal Use Production Licenses ("PUPL"

and Designated Person Production Licenses ("DPPL"

were phased out on March 31, 2014.

Enertopia Corporate Update
ACCESSWIRE - Tue Aug 05, 7:03AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Cannabis Stocks Jump as Cannabis Sativa Extends Rally
ACCESSWIRE - Mon Aug 04, 11:30AM CDT
Whitefish, MT / August 4, 2014 / The Marijuana Index(tm) moved marginally higher last week, despite a 1.7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) and an 8.68% drop in Medbox Inc. (OTC: MDBX), as many smaller index components moved higher.

Enertopia AGM Results
ACCESSWIRE - Wed Jul 23, 7:02AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
ACCESSWIRE - Tue Jul 22, 8:32AM CDT
WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.

Enertopia Makes Progress on Road to MMPR Licensed Producer Status
ACCESSWIRE - Wed Jul 16, 9:03AM CDT
WHITEFISH, MT / July 16, 2014 / Enertopia Corp. (OTC: ENRT), an aspiring licensed producer under Canada's Marihuana for Medical Purposes Regulations ("MMPR"

, has been making steady progress towards securing a license since our initial coverage and follow-up coverage detailing its three projects. While the timeline depends largely on Health Canada, management has been actively improving its facilities in preparation.

Municipal Approval for Enertopia Joint Venture in Burlington, Ontario
ACCESSWIRE - Mon Jul 14, 7:02AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

Enertopia Retains TDM Financial for Market Awareness
ACCESSWIRE - Tue Jul 01, 7:03AM CDT
Image: https://www.thenewswire.com/client_files/logo_256.png

A Closer Look at Enertopia's Three MMJ Projects
ACCESSWIRE - Mon Jun 23, 8:40AM CDT
WHITEFISH, MT / June 23, 2014 / Canada's Marijuana for Medical Purposes Regulations ("MMPR"

has attracted a lot of investor interest, as evidenced by Tweed Marijuana Inc.'s (TSX-V: TWD) (OTC: TWMJF) nearly $100 million market capitalization. Health Canada estimates that the market for legalized marijuana could surpass $1.3 billion with 450,000 patients over the next ten years, while adult use legalization could eventually add to the total.

CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains
ACCESSWIRE - Tue Jun 17, 1:00PM CDT
Whitefish, MT / June 17, 2014 / The Marijuana Index(tm) traded roughly even last week, although the sector remains well below its highs achieved earlier this year.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...